NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+6.34%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.32B
AUM Growth
+$1.32B
(+15%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
23.43%
Holding
231
New
43
Increased
51
Reduced
51
Closed
37
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$28.4M |
| 2 |
United Therapeutics
UTHR
|
$26.8M |
| 3 |
argenx
ARGX
|
$19.6M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$18.9M |
| 5 |
Sarepta Therapeutics
SRPT
|
$13.4M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$21.9M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$16.5M |
| 3 |
Repligen
RGEN
|
$14.8M |
| 4 |
BILL Holdings
BILL
|
$13.8M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
$13.6M |
Sector Composition
| 1 | Healthcare | 52.51% |
| 2 | Technology | 11.88% |
| 3 | Industrials | 9.25% |
| 4 | Consumer Discretionary | 7.08% |
| 5 | Energy | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $44.2M | 3.36% | 118,625 +52,480 | +79% | +$19.6M |
|
2
Lantheus
LNTH
$3.73B
| $31.2M | 2.37% | 378,105 +69,810 | +23% | +$5.76M |
|
3
Establishment Labs
ESTA
$1.2B
| $30.9M | 2.35% | 456,484 +89,310 | +24% | +$6.05M |
|
4
Krystal Biotech
KRYS
$4.27B
| $30M | 2.28% | 374,718 +107,629 | +40% | +$8.62M |
|
5
Legend Biotech
LEGN
$6.41B
| $29.7M | 2.26% | 615,333 +216,218 | +54% | +$10.4M |
|
|
RXDX
6
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $29.3M | 2.23% | 272,910 -10,336 | -4% | -$1.11M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $28.4M | 2.16% | 90,291 +42,050 | +87% | +$13.2M |
|
|
8
Madrigal Pharmaceuticals
MDGL
$9.76B
| $28.4M | 2.16% | +117,047 | New | +$28.4M |
|
|
KRTX
9
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $28.3M | 2.15% | 155,822 +58,694 | +60% | +$10.7M |
|
10
Transmedics
TMDX
$3.92B
| $27.8M | 2.11% | 367,408 +77,704 | +27% | +$5.88M |
|
11
Inspire Medical Systems
INSP
$2.77B
| $27.8M | 2.11% | 118,858 +37,123 | +45% | +$8.69M |
|
12
Ascendis Pharma
ASND
$11.8B
| $27M | 2.05% | 251,387 +85,450 | +51% | +$9.16M |
|
|
13
United Therapeutics
UTHR
$13.8B
| $26.8M | 2.03% | +119,506 | New | +$26.8M |
|
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $25.8M | 1.96% | 187,481 +97,091 | +107% | +$13.4M |
|
|
SWAV
15
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $24.5M | 1.86% | 112,907 +28,400 | +34% | +$6.16M |
|
16
Insulet
PODD
$23.9B
| $23.6M | 1.79% | 73,983 +24,958 | +51% | +$7.96M |
|
|
KDNY
17
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $22.5M | 1.71% | 972,191 +329,471 | +51% | +$7.63M |
|
18
Apellis Pharmaceuticals
APLS
$3.48B
| $22.2M | 1.69% | 336,951 +88,668 | +36% | +$5.85M |
|
19
Cytokinetics
CYTK
$4.23B
| $21.5M | 1.63% | 610,990 +59,862 | +11% | +$2.11M |
|
20
Day One Biopharmaceuticals
DAWN
$769M
| $21.4M | 1.63% | 1,603,390 +816,836 | +104% | +$10.9M |
|
21
Axsome Therapeutics
AXSM
$6.05B
| $21M | 1.6% | 340,430 +140,176 | +70% | +$8.65M |
|
22
Lattice Semiconductor
LSCC
$9.09B
| $20M | 1.52% | 209,436 -6,915 | -3% | -$660K |
|
23
Monolithic Power Systems
MPWR
$40B
| $19.9M | 1.52% | 39,843 -5,766 | -13% | -$2.89M |
|
|
VRNA
24
Verona Pharma
VRNA
$9.16B
| $18.9M | 1.44% | +941,300 | New | +$18.9M |
|
25
TFI International
TFII
$7.87B
| $18.7M | 1.42% | 156,493 +1,587 | +1% | +$189K |
|